Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Gemini Space Station Inc (GEMI) vs Nuwellis Inc (NUWE) Price & Performance

Gemini Space Station IncTrade
Nuwellis IncTrade

Price performance (Past 24H)

Key statistics

Gemini Space Station Inc vs Nuwellis Inc — how do they compare? Gemini Space Station Inc trades at $4.43 (market cap $579.55M), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: Gemini Space Station Inc is far larger — about 263.4× Nuwellis Inc's market cap, and Nuwellis Inc is more actively traded (121,544 versus 1,882,406). Which is the better fit depends on your goals — on Pluang, investors hold Gemini Space Station Inc for 14 Days and Nuwellis Inc for 26 Days on average.

GEMINUWE
Market Cap
$579.55M$2.20M
Volume
1,882,406121,544
Sector
FinancialsHealth
52-Week High
$25.41$146.65
52-Week Low
$3.54$0.68
Typical Hold Time
14 Days26 Days
Enterprise Value
$558.57M-$1.52M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Gemini Space Station Inc

Gemini Space Station (GEMI) trades at $4.40, down 2% today amid bearish technical signals and persistent financial losses. The company reported Q2 2026 revenue growth of 37% year-over-year but missed earnings expectations with a net loss of -$0.89 per share. Despite expanding services revenue and new product offerings, negative profit margins and cash flow challenges persist. Technical indicators show oversold conditions with RSI readings below 11, while moving averages signal continued downward pressure.

The stock faces significant fundamental headwinds with negative margins and cash burn, though analyst consensus suggests 19% upside to the $5.25 price target. Key risks include ongoing litigation, competitive pressures in financial services, and the company's ability to achieve profitability. Recent SEC approval for tokenized stock trading could provide growth opportunities if execution improves.

Nuwellis Inc

NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.

The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GEMI
100% Buy0% Sell
Avg holding period · 14 Days
NUWE
2% Buy98% Sell
Avg holding period · 26 Days

Top news

Latest headlines on both assets

About Gemini Space Station Inc

Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.

Read more on GEMI →

About Nuwellis Inc

Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.

Read more on NUWE →